Pharmaron Beijing: Trading Debut, Valuation Scenario Analysis
Pharmaron Beijing Co Ltd-H (3759 HK) is a global contract research organisation (CRO) and is one of the top three drug discovery service providers...
410 Views
Pharmaron (康龙化成) A+H: Allocation and Thoughts on Trading
Pharmaron, the second-largest contract research organization (CRO), raised USD 560 m at HKD 39.50/share. In this insight, we will cover the...
433 Views
Pharmaron Beijing IPO: H-Share Valuation Enticing
Pharmaron Beijing Co Ltd-H (3759 HK) is a global contract research organisation (CRO) and is one of the top three drug discovery service providers...
584 Views
Pharmaron (康龙化成) A+H Listing: 3Q2019 Numbers and Thoughts on Valuation
Pharmaron, a leading contract research company, is looking to list in Hong Kong by raising up to USD 600 million. In our previous note, we have...
542 Views
Pharmaron Beijing IPO: Solid 9M19, but Is It Good Enough?
Pharmaron Beijing Co., Ltd. (A) (300759 CH) is a global contract research organisation (CRO) and is one of the top three drug discovery service...
404 Views